NCT03686618View on ClinicalTrials.gov

Secretin for Acute Pancreatitis

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 1, 2019

Study Completion Date

November 1, 2019

Conditions
Pancreatitis, Acute
Interventions
DRUG

Secretin

Drug to stimulate pancreatic secretion

Trial Locations (1)

03756

RECRUITING

Dartmouth Hitchcock Medical Center, Lebanon

Sponsors

Lead Sponsor

ChiRhoClin, Inc.
All Listed Sponsors
collaborator

Dartmouth-Hitchcock Medical Center

OTHER

lead

ChiRhoClin, Inc.

INDUSTRY

NCT03686618 - Secretin for Acute Pancreatitis | Biotech Hunter | Biotech Hunter